Problem:
Paraphrase, "Clinical and policy implications The application of augmented CBT to patients with pharmacotherapy-resistant depression We recommend augmented CBT for patients with pharmaco therapy resistant depression, currently manifesting moderate/severe symptoms. This is supported by both clinical and economic perspectives. Nonetheless, there is no indication to recommend augmented CBT for patients with mild depression from a cost-effectiveness perspective. As the EQ-5D-3L-mediated ceiling effect possibly affected the results, a more accurate analysis should be performed to draw conclusions, such as an analysis with the EQ-5D-5L.